According to Zacks, “Univar Inc. is a distributor of chemicals and innovative services. The Company offers solvents, resins, pigments, acids, bases, surfactants, glycols, inorganic compounds and alcohols. It also offers transportation and warehousing infrastructure, chemicals and hazardous materials handling services. The Company’s operating geographical segments include Univar USA, Univar Canada, Univar Europe and the Middle East as well as Rest of World. It serves coatings and adhesives, food, oil and gas, personal care and pharmaceutical industries. Univar Inc. is headquartered in Downers Grove, Illinois. “
Several other research firms also recently weighed in on UNVR. Barclays PLC upped their price objective on shares of Univar from $20.00 to $21.00 and gave the stock an equal weight rating in a report on Tuesday, August 16th. Jefferies Group started coverage on shares of Univar in a report on Friday, September 9th. They issued a buy rating and a $26.00 target price for the company. Wells Fargo & Co. reiterated a hold rating on shares of Univar in a report on Sunday, September 4th. Finally, Bank of America Corp. set a $22.00 target price on shares of Univar and gave the company a buy rating in a report on Thursday, August 11th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Univar presently has a consensus rating of Buy and a consensus target price of $22.50.
Shares of Univar (NYSE:UNVR) traded up 0.28% during midday trading on Tuesday, hitting $21.55. 25,523 shares of the company were exchanged. The firm has a market capitalization of $2.97 billion, a price-to-earnings ratio of 47.05 and a beta of 1.24. Univar has a one year low of $10.65 and a one year high of $22.76. The firm’s 50 day moving average price is $20.90 and its 200 day moving average price is $19.15.
Univar (NYSE:UNVR) last released its quarterly earnings data on Tuesday, August 9th. The company reported $0.29 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.16 by $0.13. Univar had a net margin of 0.75% and a return on equity of 7.73%. The firm had revenue of $2.30 billion for the quarter, compared to the consensus estimate of $2.23 billion. During the same quarter in the prior year, the company posted ($0.12) earnings per share. The business’s revenue was down 9.9% on a year-over-year basis. Analysts forecast that Univar will post $0.72 EPS for the current fiscal year.
In other Univar news, major shareholder Nv Univar sold 20,527,358 shares of the stock in a transaction dated Thursday, August 18th. The shares were sold at an average price of $19.00, for a total transaction of $390,019,802.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Christopher Oversby sold 22,241 shares of the stock in a transaction dated Tuesday, September 20th. The stock was sold at an average price of $20.01, for a total transaction of $445,042.41. Following the transaction, the insider now owns 108,666 shares of the company’s stock, valued at approximately $2,174,406.66. The disclosure for this sale can be found here. Corporate insiders own 2.49% of the company’s stock.
A number of institutional investors have recently modified their holdings of the company. Southpoint Capital Advisors LP raised its position in shares of Univar by 4.2% in the first quarter. Southpoint Capital Advisors LP now owns 3,325,000 shares of the company’s stock worth $57,124,000 after buying an additional 135,275 shares in the last quarter. Bank of New York Mellon Corp raised its position in shares of Univar by 7.5% in the second quarter. Bank of New York Mellon Corp now owns 133,692 shares of the company’s stock worth $2,529,000 after buying an additional 9,299 shares in the last quarter. Barclays PLC raised its position in shares of Univar by 102,281.0% in the first quarter. Barclays PLC now owns 43,000 shares of the company’s stock worth $731,000 after buying an additional 42,958 shares in the last quarter. Suffolk Capital Management LLC acquired a new position in shares of Univar during the second quarter worth $2,636,000. Finally, Eos Focused Equity Management L.P. acquired a new position in shares of Univar during the second quarter worth $1,045,000. Hedge funds and other institutional investors own 80.18% of the company’s stock.
Univar Inc is a distributor of commodity and specialty chemicals. The Company’s segments include Univar USA (USA); Univar Canada (Canada); Univar Europe, the Middle East and Africa (EMEA), and Rest of World. The Rest of World segment includes developing businesses in Latin America, including Brazil and Mexico, and the Asia-Pacific region.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Univar Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Univar Inc. and related companies with MarketBeat.com's FREE daily email newsletter.